In a head and neck squamous carcinoma cell model, TGF-β2 signaling in the bone marrow activates p38α and β, resulting in a low ERK to p38 signaling ratio and dormancy of malignant disseminated tumor cells [90] (Fig. 4). The gene discussed is MAPK14; the disease is neoplasm.